Differential Effects of Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) on the Radiation Sensitivity of Normal Versus Leukemic Bone Marrow Progenitor Cell Populations

References

• Löwenberg B., Touw I. P. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993; 81: 281–292
   PubMed Web of Science ®Google Scholar
• Tavassoli M. Hematopoietic survival factors. Exp. Hematol. 1993; 21: 5111–5113
   Google Scholar
• Testa U., Pelosi E., Gabbianelli M., Fossati C., Campisi S., Isacchi G., Pescle C. Cascade transactivation of growth factor receptors in early human hematopoiesis. Blood 1993; 81: 1442–1456
   PubMed Web of Science ®Google Scholar
• Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993; 81: 2844–2855
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Karplus P. A. Hematopoietic growth factors: understanding functional diversity in structural terms. Blood 1993; 82: 3229–3240
   PubMed Web of Science ®Google Scholar
• Metcalf D. Hematopoietic regulators: redundancy or subtlety. Blood 1993; 82: 3515–3523
   PubMed Web of Science ®Google Scholar
• Neta R., Oppenheim J. J., Douches S. D. Interdependence of the radioprotective effects of human recombinant interleukin 1, tumor necrosis factor, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. 1988; 140: 108–111
   PubMed Web of Science ®Google Scholar
• Neta R., Vogel S. N., Sipe J. D., Wong G. G., Nordan R. P. Comparison of the in vivo effects of human recombinant IL1 and human recombinant IL6 in mice. Lymphokine Res. 1988; 7: 403–412
   PubMedGoogle Scholar
• Uckun F. M., Gillis S., Souza L., Song C. W. Effects of recombinant growth factors on radiation survival of human bone marrow progenitor cells. Int. J. Radiat. Oncol. Biol. Phys. 1989; 16: 415–435
   PubMed Web of Science ®Google Scholar
• FitzGerald T. J., Henault B. S., Santucci M. A., Anklesaria P., Zak S., Kase K., Farber N., Pierce J. H., Ohara A., Greenberger J. S. Recombinant murine GM-CSF increases resistance of some factor-dependent hematopoietic progenitor cells to low-dose gamma irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1989; 17: 323–335
   PubMed Web of Science ®Google Scholar
• Neta R., Vogel S. N., Plocinski J. M., Tare N. S., Benjamin W., Chizzonite R., Pilcher M. In vivo modulation with anti-interleukin-1 (IL-1) receptor (p80) antibody 35F5 of the response to IL-1. The relationship of radio-protection, colony stimulating factor, and IL-6. Blood 1990; 76: 57–62
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Souza L., Waddick K. G., Wick M., Song C. W. In vivo radioprotective effects of recombinant granulocyte colony-stimulating factor in lethally irradiated mice. Blood 1990; 75: 638–645
   PubMed Web of Science ®Google Scholar
• Waddick K. G., Song C. W., Souza L., Uckun F. M. Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination. Blood 1991; 77: 2364–2371
   PubMed Web of Science ®Google Scholar
• Waddick K. G., Uckun F. M. Effects of recombinant interleukin-3 and recombinant interleukin-6 on radiation survival of normal human bone marrow progenitor cells. Radiat. Oncol. Invest. 1993; 1: 34–40
   Google Scholar
• MacVittie T. J., Monroy R. L., Patchen M. L., Souza L. M. Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation. Int. J. Radiat. Biol. 1990; 57: 723–736
   PubMed Web of Science ®Google Scholar
• Patchen M. L., MacVittie T. J., Williams J. L., Schwartz G. N., Souza L. M. Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression. Blood 1991; 77: 472–480
   PubMed Web of Science ®Google Scholar
• Arnold R., Schmeiser T., Heit W., Frickhofen N., Pabst G., Heimpel H., Kubanek B. Hematopoietic reconstitution after bone marrow transplantation. Exp. Hematol. 1986; 14: 271–277
   PubMed Web of Science ®Google Scholar
• Barrett A. J., Adams J. A. Proliferative defect of human bone marrow after transplantation. Brit. J. Haematol. 1981; 49: 159–164
   PubMed Web of Science ®Google Scholar
• Li S., Champlin R., Fitchen J. H., Gale R. P. Abnormalities of myeloid progenitor cells after “successful” bone marrow transplantation. J. Clin. Invest. 1985; 75: 234–241
   PubMed Web of Science ®Google Scholar
• Messner N. A., Curtis J. E., Minden M. D., Tritchler D., Lockwood G., Takahashi T., Lepine J., Jamal N., Tweeddale M., Wandl U. Clonogenic hematopoietic precursors in bone marrow transplantation. Blood 1987; 70: 1425–1432
   PubMed Web of Science ®Google Scholar
• Ma D. D. F., Varga D. E., Biggs J. C. Haematopoietic reconstitution after allogeneic bone marrow transplantation in man: recovery of haematopoietic progenitors (CFU-Mix, BFU-E, and CFU-GM). Brit. J. Haematol 1987; 65: 5–10
   PubMed Web of Science ®Google Scholar
• Vellenga E., Sizoo W., Hagenbeek A., Löwenberg B. Different repopulation kinetics of erythroid (BFU-E), myeloid (CFU-GM) and T lymphocyte (TL-CFU) progenitor cells after autologous and allogeneic bone marrow transplantation. Brit. J. Haematol. 1987; 65: 137–142
   PubMed Web of Science ®Google Scholar
• Adams J. A., Gordon A. A., Jiang Y. Z., MacDonald D., McCarty D. M., Zuiable A., Treleaven J., Powles R. L., Barrett A. J. Thrombocytopenia after bone marrow transplantation for leukemia: changes in megakaryocyte growth and growth-promoting activity. Brit. J. Haematol. 1990; 75: 195–201
   PubMed Web of Science ®Google Scholar
• Henon P. R., Liang H., Beck-Wirth G., Eisenrnann J. C., Lepers M., Wunder E., Kandel G. Comparison of hematopoietic and immune recovery after autologous bone marrow transplantation. Bone Marrow Transplant. 1992; 9: 285–291
   PubMed Web of Science ®Google Scholar
• Domenech J., Linassier, Gihana C. E., Dayan A., Truglio D., Bout M., Petitdidier C., Delain M., Brémond J.-L., Desbois I., Lamagnère J.-P., Colombat P., Binet C. Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation. Blood. 1995; 85: 3320–3327
   PubMed Web of Science ®Google Scholar
• Ottman O. G., Hoelzer D., Gracien E., Ganser A., Kelly K., Reutzel R., Lipp T., Busch F. W., Schwonzen M., Heil G., Wandt H., Koch P., Kolbe K., Heyll A., Bentz M., Peters S., Diedrich H., Dethling J., Meyer P., Nowrousian M. R., Löffler B., Weiss A., Kneba M., Föoller A., Graft M., Hecht T. Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult lymphoblastic leukemia: a randomized phase III trial. Blood. 1995; 86: 444–450
   PubMed Web of Science ®Google Scholar
• Welte K., Reiter A., Mempel K., Pfetsch M., Schwab G., Schrappe M., Riehm H. A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute leukemia. Blood. 1996; 87: 3143–3150
   PubMed Web of Science ®Google Scholar
• Chelstrom L. M., Finnegan D., Uckun F. M. Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines: comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1β), interleukin 2 (IL-2). interleukin 6 (IL-6), tumor necrosis factor alpha (TNFα), granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and their combination. Leuk. Lymphoma. 1992; 7: 79–86
   PubMed Web of Science ®Google Scholar
• Waddick K. G., Finnegan D. M., Chelstrom L. M., Uckun F. M. In vivo radiosensitizing effects of recombinant interleukin 6 on radiation resistant BCL-1 B-lineage leukemia cells in acute lymphoblastic leukemia cells in a murine syngeneic bone marrow transplant model system. Leuk. Lymphoma. 1995; 19: 121–128
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Stong R., Youle R. J., Vallera D. A. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunotherapeutic approach for elimination of neoplastic T-cells from autologous marrow grafts. J. Immunol. 1985; 134: 3504–3515
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Vallera D. A., Wee S. L. B-lymphocyte regulation of human hematopoiesis. J. Immunol. 1985; 135: 3817–3822
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Chandan-Langlie M., Jaszcz W., Obuz V., Waddick K., Song C. W. Radiation damage repair capacity of primary clonogenic blasts in acute lymphoblastic leukemia. Cancer Res. 1993; 53: 1431–1436
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Song C. W. Radiobiologic features of fresh leukemic bone marrow progenitor cells in acute lymphoblastic leukemia. Cancer Res. 1988; 48: 5788–5795
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Heerema N. A. Use of leukemic progenitor cell assays for a more detailed analysis of the cytogenetic changes occurring during clonal evolution in acute lymphoblastic leukemia. Leuk. Lymphoma. 1990; 2: 1–3
   PubMedGoogle Scholar
• Uckun F. M., Fauci A. S., Song C. W., Mehta S. R., Heerema N. A., Gajl-Peczalska K. J., Ambrus J. L. B-cell growth factor receptor expression and B-cell growth factor response of leukemic B-cell precursors and B-lineage lymphoid progenitor cells. Blood 1987; 70: 1020–1034
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Ledbetter J. A. Immunobiologic differences between normal and leukemic human B-cell precursors. Proc. Natl Acad. Sci. USA 1988; 85: 8603–8607
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Kersey J. H., Vallera D. A., Ledbetter J. A., Weisdorf D., Myers D. E., Haake R., Ramsay N. K. C. Autologous bone marrow transplantation in high risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging. Blood 1990; 76: 1723–1733
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Myers D. E., Ledbetter J. A., Swaim S. E., Gajl-Peczalska K. J., Vallera D. A. Use of colony assays and highly potent anti-T-cell immunotoxins to elucidate the immunobiological features of leukemic lymphoid progenitor cells in T-lineage acute lympoblastic leukemia. J. Immunol 1988; 140: 2103–2111
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Mitchell J. B., Obuz V., Park C. H., Waddick K., Friedman N., Oubaha L., Min W. S., Song C. W. Radiation sensitivity of human B-lineage lymphoid precursor cells. Int. J. Radiat. Oncol. Biol. Phys. 1991; 21: 1553–1560
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Ramsay N. K. C., Waddick K. G., Jaszcz W., Chandan-Langlie M., Obuz V., Haake R., Gajl-Peczalska K., Kersey J. H., Song C. W. In vitro and in vivo radiation resistance associated with CD3 surface antigen expression in T-lineage acute lymphoblastic leukemia. Blood 1991; 78: 2945–2955
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Mitchell J. B., Obuz V., Chandan-Langlie M., Min W. S., Haissig S., Song C. W. Radiation and heat sensitivity of human T-lineage acute lymphoblastic leukemia (ALL) and acute myeloblastic leukemia (AML) clones displaying multiple drug resistance (MDR). Int. J. Radiat. Oncol. Biol Phys. 1992; 23: 115–125
   PubMed Web of Science ®Google Scholar
• Champlin R., Gale R. P. Acute lymphoblastic leukemia: recent advances in biology and therapy. Blood. 1989; 73: 2051–2066
   PubMed Web of Science ®Google Scholar
• Poplack D. G., Reaman G. Acute lymphoblastic leukemia in childhood. Pediatric Clinics of North America. 1988; 35: 903–932
   PubMed Web of Science ®Google Scholar
• Abshire T. C., Buchanan G. R., Jackson J. F., Shuster J. J., Brock B., Head D., Behm F., Crist W. M., Link M., Borowitz M., Pullen D. J. Morphologic, immunologic, and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study. Leukemia 1992; 6: 357–362
   PubMed Web of Science ®Google Scholar
• Ramsay N., LeBien T. W., Nesbit M., McGlave D., Weisdorf D., Kenyon P., Hurd D., Goldman A., Kim T., Kersey J. Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement. Blood 1985; 66: 508–513
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Kersey J. H., Haake R., Weisdorf D., Ramsay N. K. C. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging. Blood 1992; 79: 1094–1104
   PubMed Web of Science ®Google Scholar
• Barrett A. J., Horowitz M. M., Gale R. P., Biggs J. C., Camitta B. M., Dicke K. A., Gluckman E., Good R. A., Herzig R. H., Lee M. B., Marmont A. M., Masaoka T., Ramsay N. K. C., Rimm A. A., Speck B., Zwaan F. E., Bortin M. M. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 1989; 74: 862–871
   PubMed Web of Science ®Google Scholar
• Woods W. G., Ramsay N. K. C., Weisdorf D. J., Haake R., Vallera D. A., Kim T. H., Lasky L., Nesbit M. E., Bostum B., Uckun F. M., Goldman A. I., Kersey J. H. Bone marrow transplantation for acute lymphoblastic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside. Lack of superiority over cyclophosphamide containing regimens. Bone Marrow Transplant 1990; 6: 9–16
   PubMed Web of Science ®Google Scholar
• Prentice H. G., Burnett A. K., Simonsson B., Brenner M. K., Gottlieb D. J., Totterman T., Gilmore M., Heslop H., Reittie J. E., Bianchi A., Grob J., Hann I. M. ABMT versus chemotherapy in high risk acute lymphoblastic leukemia. Autologous bone marrow transplantation. Proceedings of the 4th International Symposium, Texas. K. A. Dicke, G. Spitzer, S. Jagannath, M. J. Eringer-Hodzesleds. 1989; 139
   Google Scholar
• Kersey J. H., Weisdorf D., Nesbit M. E., LeBien T. W., Woods W. G., McGlave P. B., Kim T., Vallera D. A., Goldman A. I., Bostrom B. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N. Engl. J. Med. 1987; 317: 361–467
   Web of Science ®Google Scholar
• Dopfer R., Henze G., Bender-Gotze C., Ebell W., Ehninger G., Friedrich W., Gadner H., Klingebiel T., Peters C., Riehm H., Suttorp M., Schmitz N., Siegert W., Stollman-Gibbels B., Hartmann R., Niethammer D. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM-and CoALL-Protocols: results of the German cooperative study. Blood 1991; 78: 2780–2784
   PubMed Web of Science ®Google Scholar
• Dicke K. A., Spitzer G. F. Clinical studies of autografting in acute lymphoblastic leukemia. Clin. Hematol. 1986; 15: 86
   Google Scholar
• Doney K., Buckner C. D., Kopecky K. J., Sanders J. E., Appelbaum F. R., Clift R., Sullivan K., Witherspoon R., Storb R., Thomas E. D. Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission. Bone Marrow Transplant 1987; 2: 355
   PubMed Web of Science ®Google Scholar
• Coccia P. F., Strandjord S. E., Warkentin P. I., Cheung N. V., Gordon E. M., Novak L. J., Shina D. C., Herzig R. H. High dose cytosine arabinoside and fractionated total body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission. Blood 1988; 71: 888
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Kersey J. H., Vallera D. A., Ledbetter J. A., Weisdorf D., Myers D. E., Haake R., Ramsay N. K. C. Autologous bone marrow transplantation in high risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging. Blood 1990; 76: 1723–1733
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Kersey J. H., Haake R., Weisdorf D., Nesbit M. E., Ramsay N. K. C. Pretransplant leukemic cell burden as a predictor of relapse after autologous bone marrow transplantation for high risk remission acute lymphoblastic leukemia. N. Engl. J. Med. 1993; 329: 1296–1301
   PubMed Web of Science ®Google Scholar
• Dicke K. A. Summary report on marrow purging symposium. New strategies in bone marrow transplantation, R. P. Gale, R. E. Champlin. Wiley-Liss, New York 1991; 185–191
   Google Scholar
• Santos G. W., Kaiser H. In vitro chemotherapy as a prelude to autologous marrow transplantation in hematologic malignancy. Minimal residual disease in acute leukemia, B. Löwenberg, A. Hagenbeek. A. Martinus Nijhoff Publishers, Boston, NY 1984; 165–170
   Google Scholar
• Uckun F. M., Kim T. H., Ramsay N. C., Min W. S., Song C. W. Radiobiological heterogeneity of leukemic lymphocyte precursors from acute lymphoblastic leukemia patients. Int. J. Radiat. Biol. 1989; 56: 611–615
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Jaszcz W., Chandan-Langlie M., Waddick K. G., Gajl-Peczalska K., Song C. W. Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia. J. Clin. Invest. 1993; 91: 1044–1051
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Aeppli D., Song C. W. Radiation resistance of primary clonogenic blasts from children with acute lymphoblastic leukemia. Int. J. Radiat. Oncol Biol. Phys. 1993; 27: 899–906
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Song C. W. Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts. Blood 1993; 81: 1323–1332
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Song C. W., Nesbit M., Kersey J. H., Ramsay N. K. C. Immunophenotype predicts radiation resistance in T-lineage acute lymphoblastic leukemia and T-lineage non-Hodgkin's lymphoma. Int. J. Radiat. Oncol. Biol. Phys. 1992; 24: 705–712
   PubMed Web of Science ®Google Scholar
• Deschavanne P. J., Mailaise E. P. The relevance of α/β ratios determined in vitro for human cell lines to the understanding of in vivo values. Int. J. Radiat. Biol. 1989; 56: 539–542
   PubMed Web of Science ®Google Scholar
• Fertil B., Mailaise E. P. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 11 published curves. Int. J. Radiat. Oncol. Biol. Phys. 1985; 11: 1699–1707
   PubMed Web of Science ®Google Scholar
• Mailaise E. P., Fertil B., Deschavanne P. J., Chavaudra N., Brock W. A. Initial slope of radiation survival curves is characteristic of the origin of primary and established cultures of human tumor cells and fibroblasts. Radiat. Res. 1987; 111: 319–333
   PubMed Web of Science ®Google Scholar
• Rofstad E. K., Wahl A., Brustad T. Radiation sensitivity in vitro of cells isolated from human tumor surgical specimens. Cancer Res. 1987; 47: 106–110
   PubMed Web of Science ®Google Scholar
• Steel G. G., Courtenay V. D. The radiobiology of human tumor cells. The biological basis of radiotherapy, W. Steel, M. Adams, J. H. Peckham. Elsevier Science Publishers B.V., Amsterdam 1983; 123–137
   Google Scholar
• Weichselbaum R. R., Nove J., Little J. B. X-ray sensitivity of human tumor cells in vitro. Int. J. Radiat. Oncol. Biol. Phys. 1980; 6: 437–440
   PubMed Web of Science ®Google Scholar
• Weichselbaum R. R., Rotmensch J., Ahmed-Swan S., Beckett M. A. Radiobiological characterization of 53 human tumor cell lines. Int. J. Radiat. Biol 1989; 56: 553–560
   PubMed Web of Science ®Google Scholar
• Weichselbaum R. R., Dahlberg W., Little J. B. Inherently radioresistant cells. Proc. Natl. Acad. Sci. USA 1985; 82: 4732–4735
   PubMed Web of Science ®Google Scholar
• Yoshida T., Nakamura S., Ohtake S., Okafuji K., Kobayashi K., Kondo K., Kanno M., Matano S., Matsuda T., Kanai M., Sugimoto R., Ogawa M., Takaku F. Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma. Cancer 1990; 66: 1904–1909
   PubMed Web of Science ®Google Scholar
• Pettengell R., Gurney H., Radford J. A., Deakin D. P., James R., Wilkinson P. M., Kane K., Bentley J., Crowther D. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood 1992; 80: 1430–1436
   PubMed Web of Science ®Google Scholar
• Ohno R., Tomonaga M., Kobayashi T., Kanamura A., Shirakawa S., Masaoka T., Omine M., Oh H., Nomura T., Sakai Y., Hirano M., Yokomaku S., Nakayama S., Yoshida Y., Miura A. B., Morishima Y., Dohy H., Niho Y., Hamajima N., Takaku F. Effects of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N. Engl. J. Med. 1990; 323: 871–877
   PubMed Web of Science ®Google Scholar
• Sheridan W. P., Morstyn G., Wolf M., Dodds A., Lusk J., Maher D., Layton J. E., Green M. D., Souza L., Fox R. M. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; 2: 891–895
   PubMed Web of Science ®Google Scholar
• Schriber J. R., Negrin R. S., Chao N. J., Long G. D., Horning S. J., Blume K. G. The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrow. Leukemia. 1993; 7: 1491–1495
   PubMed Web of Science ®Google Scholar
• Taylor K. M., Jagannath S., Spitzer G., Spinolo J. A., Tucker S. L., Fogel B., Cabanillas F. F., Hagemeister F. B., Souza L. M. Recombinant human granulocyte colony-stimulating factor hastens recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J. Clin. Oncol. 1990; 7: 1791–1799
   Web of Science ®Google Scholar
• Kaczmarski R. S., Mufti G. J. The cytokine receptor superfamily. Blood Reviews. 1991; 5: 193–203
   PubMed Web of Science ®Google Scholar
• Matsuda T., Yakahashi-Tezuka M., Fukuda T., Okuyama Y., Fujitana Y., Tsukada S., Mano H., Hirai H., Witte O. N., Hirano T. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood. 1995; 85: 627–633
   PubMed Web of Science ®Google Scholar
• Nishimura C., Watanabe A., Gouda H., Shimada I., Arata Y. Folding topologies of human interleukin-6 and its mutants as studied by NMR spectroscopy. Biochemistry 1996; 35: 273–281
   PubMed Web of Science ®Google Scholar
• Bruce A. G., Hoggatt I. H., Rose T. M. Oncostatin M is a differentiation factor for myeloid leukemia cells. J. Immunol 1992; 149: 1271–1275
   PubMed Web of Science ®Google Scholar
• Scopes J., Daly S., Atkinson R., Ball S. E., Fordon-Smith E. C., Gibson F. M. Aplastic anemia: evidence for dysfunctional bone marrow progenitor cells and the corrective effect of granulocyte colony-stimulating factor in vitro. Blood. 1996; 87: 3179–3185
   PubMed Web of Science ®Google Scholar
• Fukushima N., Nishina H., Koishhara Y., Ohkawa H. Enhanced hematopoiesis in vivo and in vitro by splenic stromal cells derived from the mouse with recombinant granulocyte colony-stimulating factor. Blood. 1992; 80: 1914–1922
   PubMed Web of Science ®Google Scholar
• Ikebuchi K., Clark S. C., Ihle J. N., Souza L. M., Ogawa M. Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hematopoietic progenitors. Proc. Natl. Acad. Sci. USA. 1988; 85: 3445–3449
   PubMed Web of Science ®Google Scholar
• Leary A. G., Ikebuchi K., Hirai Y., Wong G. G., Yang Y. C., Clark S. C., Ogawa M. Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha. Blood 1988; 71: 1759–1763
   PubMed Web of Science ®Google Scholar
• Tsuji K., Zsebo K. M., Ogawa M. Enhancement of murine blast cell colony formation in culture by recombinant rat stem cell factor, ligand for c-kit. Blood 1991; 78: 1223–1229
   PubMed Web of Science ®Google Scholar
• Tohda S., Minden M. D. Modulation of growth factor receptors on acute myeloblastic leukemia cells by retinoic acid. Jap. J. Cancer Res. 1994; 85: 378–383
   PubMedGoogle Scholar
• Gianni M., Terao M., Zanotta S., Barbui T., Ramaldi A., Garattini E. Retinoic acid and granulocyte colony-stimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells. Blood. 1994; 83: 1909–1921
   PubMed Web of Science ®Google Scholar
• Dubois C., Schlageter M. H., De Gentile A., Guidez F., Balitrand N., Toubert M. E., Krawice I., Fenaux P., Castaigne S., Najean Y. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood. 1994; 83: 3264–3270
   PubMed Web of Science ®Google Scholar
• Touw I., Donath J., Pouwels K., Van Buitenen, Schipper C. P., Santini V., Hagemeijer A., Löwenberg B., Delwel R. Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5. Leukemia. 1991; 5: 687–692
   PubMed Web of Science ®Google Scholar
• Eto T., Akashi K., Harada M., Shibuya T., Takamatsu Y., Teshima T., Niho Y. Biological characteristics of CD7 positive acute myelogenous leukaemia. Brit. J. Haematol. 1992; 82: 508–514
   PubMed Web of Science ®Google Scholar
• Uckun F. M. Regulation of human B-cell ontogeny. Blood. 1990; 76: 1908–1923
   PubMed Web of Science ®Google Scholar
• Shimizu S., Hirano T., Yoshioka R., Sugai S., Matsuda T., Yaga T., Kishimoto T. Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3). Blood. 1988; 72: 1826–1828
   PubMed Web of Science ®Google Scholar
• Taga T., Kawanishi Y., Hardy R. R., Hirano T., Kishimoto T. Receptors for B cell stimulatory factor 2. Quatitation, specificity, distribution, and regulation of their expression. J. Exp. Med. 1987; 166: 967–981
   PubMed Web of Science ®Google Scholar
• Drach D., Estrov Z., Zhao S., Drach J., Cork A., Collins D., Kantajarian H., Andreeff M. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, PIXY-321, stem cell factor, interleukin-3. and interleukin-7: receptor-binding and effects on clonogenic proliferation in acute lymphoblastic leukemia. Leak. Lymphoma. 1994; 16: 79–88
   PubMed Web of Science ®Google Scholar
• Kita K., Nishii K., Ohishi K., Morita N., Takakura N., Kawakami K., Miwa H., Shirakawa S. Frequent gene expression of granulocyte colony-stimulating factor (G-CSF) receptor in CD7+ surface CD3- acute lymphoblastic leukaemia. Leukemia. 1993; 7: 1184–1190
   PubMed Web of Science ®Google Scholar
• Park L. S., Waldron P. E., Friend D., Sassenfeld H. M., Price V., Anderson D., Cosman D., Andrews R. G., Bernstein I. D., Urdal D. L. Interleukin-3, GM-CSF, and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsiveness. Blood 1989; 74: 56–65
   PubMed Web of Science ®Google Scholar
• Inukai T., Sugita K., Iijima K., Tezuka T., Goi K., Kojika S., Shiraishi K., Kagami K., Nakazawa S. Expression of granulocyte colony-stimulating factor receptor on CD10-positive human B-cell precursors. Brit. J. Haematol. 1995; 89: 623–626
   PubMed Web of Science ®Google Scholar
• Meckenstock G., Heyll A., Schneider E. M., Hildebrandt B., Runde V., Aul C., Bertram C. R., Ludwig W. D., Scheider W. Acute leukemia coexpressing myeloid, B-, and T-lineage associated markers: multiparameter analysis of criteria defining lineage commitment and maturational stage in a case of undifferentiated leukemia. Leukemia. 1995; 9: 260–264
   PubMed Web of Science ®Google Scholar
• Higashigawa M., Komada Y., Washio N., Kuwabara H., Hori H., Ido M., Sakurai M. Recombinant human granulocyte colony-stimulating factor enhanced cytotoxocity of Ara-C in Ara-C-resistant leukemia cells from a patient with biphenotypic leukemia in cell kinetic quiescence. Leukemia Res. 1992; 16: 1049–1054
   PubMed Web of Science ®Google Scholar
• Shimoda K., Okamura S., Harada N., Ikematsu W., Kondo S., Kawasaki C., Tanaka T., Etou T., Akashi K., Okamura T. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemia cells possess granulocyte colony-stimulating factor receptors. Cancer Res. 1992; 52: 3052–3055
   PubMed Web of Science ®Google Scholar
• Tamura M., Hattori K., Ono M., Hata S., Hayata I., Asano S., Bessho M., Kunitake H. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) on murine myeloid leukemia: stimulation of proliferation of leukemic cells in vitro and inhibition of development of leukemia in vivo. Leukemia 1989; 3: 853–858
   PubMed Web of Science ®Google Scholar
• Baer M. R., Bernstein S. H., Brunette V. L., Heinonen K., Mrózek K., Swann V. L., Minderman H., Block A. M. W., Pixley L. A., Christiansen N. P., Fay J. W., Barcos M., Rustum Y., Herzig G. P., Bloomfield C. D. Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia. Blood 1996; 87: 1484–1494
   PubMed Web of Science ®Google Scholar
• Ohno R., Naoe T., Kanamaru A., Yoshida M., Hiraoka A., Kobayashi T., Ueda T., Minami S., Morishima Y., Saito Y., Furusawa S., Imai K., Takemoto Y., Miura Y., Teshima H., Hamajima N. Kohseisho Leukemia Study Group: a double blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Blood 1994; 83: 2086–2092
   PubMed Web of Science ®Google Scholar
• Estey E., Thall P., Andreeff M., Beran M., Kantajarian H., O'Brien S., Escudier S., Robertson L. E., Roller C., Kornblau S., Pierce S., Freireich E. J., Dreisseroth A., Keiting M. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. J. Clin. Oncol. 1994; 12: 671–678
   PubMed Web of Science ®Google Scholar
• Lotem J., Sachs L. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukaemia cells. Blood 1992; 80: 1750–1757
   PubMed Web of Science ®Google Scholar
• Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wild-type p53 induces apoptosis of myeloid leukemia cells that is inhibited by interleukin-6. Nature 1991; 352: 345–347
   PubMed Web of Science ®Google Scholar
• Crawford J., Ozer H., Stoller R., Johnson D., Lyman G., Tabbara I., Kris ML, Grous J., Picozzi V., Rausch G., Smith R., Gradishar W., Yahanda A., Vincent ML, Stewart M., Glaspy J. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N. Engl. J. Med. 1991; 325: 164–170
   PubMed Web of Science ®Google Scholar
• Bronchud M. H., Scarffe J. H., Thatcher N., De Crowther A. L., Souza L. M., Alton N. K., Testa N. G., Dexter T. M. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small-cell lung cancer. Brit. J. Cancer 1987; 56: 809–813
   PubMed Web of Science ®Google Scholar
• Kotake T., Miki T., Akaza H., Kubota Y., Mishio Y., Matsumura Y., Ota K., Ogawa N. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with urogenital cancer. Cancer Chemother. Pharmacol. 1991; 27: 253–257
   PubMed Web of Science ®Google Scholar
• Neidhart J., Mangalik A., Kohler W., Stidley C., Saiki J., Duncan P., Souza L., Downing M. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation. J. Clin. Oncol. 1989; 7: 1685–1692
   PubMed Web of Science ®Google Scholar